Company profile
Conavi Medical Corp.
OTC: CNVIF · Healthcare · Medical - Devices
Canadian filerHQ Toronto, ONCIK 0000840551Reports USD
#1 of 1,418 Healthcare companies by revenue
EA Score
——FH —DQ —GM —SS 22
v0.1 · 5/100 weight · pillars only
↑ balance-sheet leverage, return on assets · ↓ listing tenure, workforce scale
Methodology →Revenue TTM
$606.9k
Rev growth YoY (TTM)
-90.0%
Net income (FY)
-$14.9M
Employees
4
as of 2026-08-21
Market cap
$11.4M
as of 2026-08-21
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Net income-$14.9M-$14.9M2021
Total assets$47.2M$47.2M2021
Liabilities$11.9M$11.9M2021
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Conavi Medical Corp.’s financial profile?
Conavi Medical Corp. earned -$14.9M in FY2021 net income.
Peers · Healthcare
Brainstorm Cell Therapeutics Inc.——Jasper Therapeutics, Inc.——PDS Biotechnology Corporation——Advanced Biomed Inc. Common Stock——Medicure Inc.——Skye Bioscience, Inc.——Key facts
CEOThomas Looby
SectorHealthcare
IndustryMedical - Devices
HeadquartersToronto, ON
ExchangeOTC: CNVIF
Employees4
IPO date2024-10-14
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.